CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
EVIDENCE BASED MEDICINE;
GESTURE;
HAMILTON SCALE;
HUMAN;
MAJOR DEPRESSION;
MENTAL INSTABILITY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROFESSIONAL MISCONDUCT;
PUBLICATION;
PUBLISHING;
SHORT SURVEY;
SIDE EFFECT;
SUICIDAL IDEATION;
ADOLESCENT;
AGE;
ARTICLE;
ADOLESCENT;
AGE FACTORS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
EDITORIAL POLICIES;
HUMANS;
PAROXETINE;
PERIODICALS AS TOPIC;
RETRACTION OF PUBLICATION AS TOPIC;
Efficacy of paroxetine in the treatment of adolescent major depression: A randomized controlled trial
Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Child Adolesc Psychiatry 2001;40:762-72.
Guest authorship and ghostwriting in publications related to rofecoxib, a case study of industry documents from rofecoxib litigation
Ross JS, Hill KP, Egilman DS, Krumholz HM: Guest authorship and ghostwriting in publications related to rofecoxib, a case study of industry documents from rofecoxib litigation. JAMA 2008;299:1800-122.
Narrative review: The promotion of gabapentin: an analysis of internal industry documents
Steinman MA, Bero LA, Chrenn MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 2006;145:284-93.
International Committee of Medical Journal Editors. Corrections, retractions and "expressions of concern." www.icmje.org/publishing- 2corrections.html.
Martin A, Faraone SV, Henderson SW, Hudziak JJ, Leibenluft E, Piacentini J, et al. Conflict of interest. J Am Acad Child Adolesc Psychiatry 2008;47:119-20.